Cargando…
The plasminogen activating system in the pathogenesis of Alzheimer’s disease
Dementia is a clinical syndrome that affects approximately 47 million people worldwide and is characterized by progressive and irreversible decline of cognitive, behavioral and sesorimotor functions. Alzheimer’s disease (AD) accounts for approximately 60–80% of all cases of dementia, and neuropathol...
Autor principal: | Yepes, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343336/ https://www.ncbi.nlm.nih.gov/pubmed/33642369 http://dx.doi.org/10.4103/1673-5374.308076 |
Ejemplares similares
-
The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain
por: Yepes, Manuel
Publicado: (2019) -
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
por: Yepes, Manuel, et al.
Publicado: (2021) -
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
por: Yepes, Manuel
Publicado: (2015) -
Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
por: Yepes, Manuel
Publicado: (2019) -
Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system
por: Jeanneret, Valerie, et al.
Publicado: (2017)